secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001601830-25-000152
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Roche exercises option for Recursion's Microglia Map; $30M fee
--------------------------------------------------------------

- Roche exercised option for a first-of-its-kind whole genome map of brain immune cells (Microglia Map) from Recursion.
- Recursion will receive a $30 million Acceptance Fee from Roche under the 2021 Collaboration and License Agreement.
- The Microglia Map is generated by Recursion's platform as part of the ongoing partnership with Roche.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183025000152/0001601830-25-000152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183025000152/rxrx-20251029.htm
  HTML page:      https://secwatch.observer/filing/0001601830-25-000152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer